Here you can find a collection of publications by ESCMID.

Go directly to:

• Medical Guidelines
• Position Papers
• EUCAST
• EITaF
• EUCIC
• Publications from Study Groups
• Publications from recipients of Research Grants

• Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary Daley C L, Iaccarino J M, Jr, Lange C, et al. Clin. Infect. Dis. 2020 doi:10.1093/cid/ciaa241
• Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease Lantos PM, Rumbaugh J, Bockenstedt LK et al. Clin. Infect. Dis. 2020 doi:10.1093/cid/ciaa1215

EFISG

• Invasive Pulmonary Aspergillosis treatment duration in haematology patients in Europe: an EFISG, IDWP‐EBMT, EORTC‐IDG, SEIFEM survey
  Lanternier F, Seidel D, Pagano L, et al. Mycoses 2020. doi: 10.1111/myc.13056
• MixInYeast: A Multicenter Study on Mixed Yeast Infections
  Medina N, Soto-Debrán JC, Seidel D et al. J Fungi (Basel) 2020; 7:13. doi: 10.3390/jof7010013
  
  

EFWISG

• Food-to-Humans Bacterial Transmission.
  Antunes P, Novais C, Peixe L. Microbiol Spectr 2020;8(1). doi: 10.1128/microbiolspec.MTBP-0019-2016.

EPASG

• Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARSCoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents the PK/PD of Anti-Infectives Study Group (EPASG) of the European Society.
  Zeitlinger M, Koch B C P, Bruggemann R et al. Clin Pharmacokinet 2020; 59: 1195–1216. doi: 10.1007/s40262-020-00924-9
  
  

ESGAI

• A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects.
  Sóki J, Wybo I, Hajdú E, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2020.102182.
• Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study.
  Veloo ACM, Tokman HB, Jean-Pierre H, et al. Anaerobe 2020 doi: 10.1016/j.anaerobe.2019.102111.
• Detection of beta-lactamase production in clinical Prevotella species by MALDI-TOF MS method.
  Toprak NU, Akgul O, Sóki J et al. Anaerobe 2020; 65: 102240. doi: 10.1016/j.anaerobe.2020.102240.
• Ceftriaxone treatment of spondylodiscitis and other serious infections with Cutibacterium acnes.
  Tiltnes T S, Kehrer M, Hughes H et al. J Antimicrob Chemother 2020; 75:3046-3048. doi: 10.1093/jac/dkaa259
  
  

ESGAP

• COVID-19: don't neglect antimicrobial stewardship principles!
  Huttner B.D., Catho G., Pano-Pardo J.R. et al. Clin Microbiol Infect 2020; 26:808-810. doi:10.1016/j.cmi.2020.04.024
  
  

ESGB

• Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates
  Allkjaa J, Bjarnsholt T, Coenye T, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100010
• The future of biofilm research – Report on the ‘2019 Biofilm Bash’
  Coenye T, Kjellerup B, Stoodley P, et al. Biofilm 2020. doi:10.1016/j.bioflm.2019.100012.

ESGBIES

• Bloodstream infections - Standard and progress in pathogen diagnostics.
  Lamy B, Sundqvist M, Idelevich EA et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.11.017.

ESGBOR

• Unconventional diagnostic tests for Lyme borreliosis: a systematic review.
  Raffetin A, Saunier A, Bouiller K, et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.06.033.
• Rejection of the name Borreliella and all proposed species comb. nov. placed therein.
  Margos G, Castillo-Ramirez S, Cutler S, et al. Int J Syst Evol Microbiol 2020 doi: 10.1099/ijsem.0.004149.
• Lyme Borreliosis with Scalp Eschar Mimicking Rickettsial Infection, Austria. Markowicz M, Schötta AM, Wijnveld M et al. Emerg. Infect. Dis 2020; 26:2193-2195. doi:10.3201/eid2609.191256.

ESGCD

• The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016.
  Novakova E, Stefkovicova M, Kopilec MG, et al. Int J Infect Dis 2020 doi: 10.1016/j.ijid.2019.10.038.
• Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
  Freeman J, Vernon J, Pilling S, et al. Eur J Clin Microbiol Infect Dis 2020 doi: 10.1007/s10096-019-03708-7.
• Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.
  Azimirad M, Krutova M, Yadegar A et al. Emerg Microbes Infect 2020; 9:1432-1443. doi: 10.1080/22221751.2020.1780949
• An Outbreak of Clostridium (Clostridioides) difficile Infections within an Acute and Long-Term Care Wards Due to Moxifloxacin-Resistant PCR Ribotype 176 Genotyped as PCR Ribotype 027 by a Commercial Assay.  Novakova E, Kotlebova N, Gryndlerova A et al. J Clin Med 2020 20; 9:3738. doi: 10.3390/jcm9113738.
• Diagnostic and therapy of severe Clostridioides difficile infections in the ICU.
  Guery B, Barbut F, Tschudin-Sutter S Curr Opin Crit Care 2020 ;26: 450-458. doi: 10.1097/MCC.0000000000000753.
• COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients.
  Spigaglia P Anaerobe 2020; 64: 102233. doi: 10.1016/j.anaerobe.2020.102233.
• Molecular characterization of pathogenicity locus (PaLoc) and tcdC genetic diversity among tcdA+B+Clostridioides difficile clinical isolates in Tehran, Iran.
  Kodoriab M, Ghalavanda Z, Yadegar A et al. Anaerobe 2020; 67: 102294. doi: 10.1016/j.anaerobe.2020.102294.
  
  

ESGHAMI

• Respiratory Mycobiome and Suggestion of Inter-Kingdom Network During Acute Pulmonary Exacerbation in Cystic Fibrosis
  Soret  P, Vandenborght  LE, Francis  F et al. Sci Rep. 2020 doi: 10.1038/s41598-020-60015-4.
• A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group.
  Keller J J, Ooijevaar R E, Hvas C L et al. United European Gastroenterol J 2020; 2050640620967898. doi: 10.1177/2050640620967898.
• Microbiome in the setting of burn patients: implications for infections and clinical outcomes.
  Corcione S, Lupia T, De Rosa F G et al. Burns & Trauma 2020; 8. tkaa033. doi: 10.1093/burnst/tkaa033.
  
  

ESGIAI

• Lower success rate of débridement and implant retention in late acute versus early acute periprosthetic joint infection caused by Staphylococcus spp. results from a matched cohort study.
  Wouthuyzen-Bakker M, Sebillotte M, Huotari K, ESCMID Study Group for Implant-Associated Infections (ESGIAI), et al. Clin Orthop Relat Res 2020. doi: 10.1097/CORR.0000000000001171.
• Propionibacterium/Cutibacterium species-related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospital.
  Broly M, Ruffier d'Epenoux L, Guillouzouic A, et al. Eur J Clin Microbiol Infect Dis 2020; 39:1357-1364. doi: 10.1007/s10096-020-03852-5.
• How to handle concomitant asymptomatic prosthetic joints during an episode of hematogenous PJI, a multicentre analysis.
  Wouthuyzen-Bakker M, Sebillotte M, Arvieux C et al. Clin Infect Dis 2020; ciaa1222. doi: 10.1093/cid/ciaa1222.
• The impact of surgical strategy and rifampin on treatment outcome in Cutibacterium periprosthetic joint infections.
  Achermann Y, Kusejko K, Auñón A et al. Clin Infect Dis 2020; ciaa1839. doi: 10.1093/cid/ciaa1839.
• 2020 Frank Stinchfield Award: Identifying who will fail following irrigation and debridement for prosthetic joint infection.
  Shohat N, Goswami K, Tan T L et al. Bone Joint J 2020; 102-B:11–19. doi:10.1302/0301-620x.102b7.bjj-2019-1628.r1.
  
  

ESGIB

• Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study.
  Popescu CP, Florescu SA, Hasbun R, et al. J Clin Virol. 2020 doi: 10.1016/j.jcv.2019.104213.
• A Prospective Cohort Study to Identify Clinical, Biological and Imaging Features That Predict Etiology of Acute Encephalitis
  Le Maréchal  M, Mailles  A, Seigneurin  A et al. Clin Infect Dis 2020 doi: 10.1093/cid/ciaa598.
• Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
  Ricci S, Grandgirard D, Masouris I et al. BMC Infect Dis2020; 20: 505. doi. 10.1186/s12879-020-05226-w.
  
  

ESGIE

• Considerations for the optimal management of antibiotic therapy in elderly patients.
  Falcone M, Paul M, Tiseo G, et al. J Glob Antimicrob Resist 2020 doi: 10.1016/j.jgar.2020.02.022.
• A systematic review assessing the under-representation of elderly adults in COVID-19 trials.
  Prendki V, Tau N, Avni T et al. BMC Geriatrics BMC Geriatr 2020 doi: 10.1186/s12877-020-01954-5.
  
  

ESGITM

• Parasitic skin infections: neglected diseases or just challenging for diagnosis?
  Gardini G, Tomasoni LR, Castelli F. Curr Opin Infect Dis 2020. doi: 10.1097/QCO.0000000000000634.
• Extrapulmonary tuberculosis among migrants in Europe, 1995 to 2017.
  Hayward S E, Rustage K, Nellums L B et al. Clin Microbiol Infect 2020; in press. doi: 10.1016/j.cmi.2020.12.006.
• "It's a life you're playing with": A qualitative study on experiences of NHS maternity services among undocumented migrant women in England.
  Nellums L B, Powis J, Jones L et al. Soc Sci Med 2020; 270: 113610. doi: 10.1016/j.socscimed.2020.113610.
• Delivering multi-disease screening to migrants for latent TB and blood-borne viruses in an emergency department setting: a feasibility study.
  Hargreaves S, Nellums L B, Johnson C et al. J Trav Med Infect Dis 2020; 36: 101611.  doi: 10.1016/j.tmaid.2020.101611.
• Strengthening screening for infectious diseases and vaccination among migrants in Europe: what is needed to close the implementation gaps?
  Noori T, Hargreaves S, Greenaway C et al. Trav Med Infect Dis 2020, in press. doi: 10.1016/j.tmaid.2020.101715.
  
  

ESGLI

• A real-time PCR for specific detection of the Legionella pneumophila serogroup 1 ST1 complex.
  Ginevra C, Chastang J, David S et al. Clin Microbiol Infect 2020 doi: 10.1016/j.cmi.2019.09.002.

ESGMAC

• Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016.
  Beeton ML, Zhang XS, Uldum SA, et al. Euro Surveill 2020 doi: 10.2807/1560-7917.ES.2020.25.2.1900112.

ESGMD

• Core/whole genome multilocus sequence typing and core genome SNP-based typing of OXA-48-producing Klebsiella pneumoniae clinical isolates from Spain.
  Miro E, Rossen JWA, Chlebowicz MA, et al. Front Microbiol 2020 doi: 10.3389/fmicb.2019.02961.

ESGMYC

• Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary.Daley C L, Iaccarino J M, Lange C et al. Clin Infect Dis. 2020; 71: e1-e36. doi: 10.1093/cid/ciaa241.
• Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries?  Méchaï F, Cordel H, Guglielmetti L et al. Front Public Health. 2020; 8: 443. doi: 10.3389/fpubh.2020.00443.
• Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Ong CWM, Migliori GB, Raviglione M et al. Eur Respir J. 2020; 56:2001727. doi: 10.1183/13993003.01727-2020.

ESGREV

• Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives

  Nelson PP, Rath  BA, Fragkou  PC et al Front Cell Infect Microbiol 2020 doi: 10.3389/fcimb.2020.00181
• Review of trials currently testing treatment and prevention of COVID-19.
  Fragkou P C, Belhadi D,Peiffer-Smadja N et al. Clin Microbiol Infect 2020; 26:988-998. doi: 10.1016/j.cmi.2020.05.019.
  
  

ESGS

• Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
  Wirth T, Bergot M, Rasigade JP, et al. Nat Microbiol 2020 doi: 10.1038/s41564-020-0676-2.

ESGVH

• Elimination of hepatitis C in Europe: can WHO targets be achieved?
  Maticic M, Lombardi A, Mondelli MU, et al. Clin Microbiol Infect 2020  doi: 10.1016/j.cmi.2020.01.014.

ESGVM

• Driving laboratory standardisation of bacterial culture and antimicrobial susceptibility testing in veterinary clinical microbiology in Europe and beyond.
  Timofte D, Broens E, Guardabassi L et al. J Clin Microbiol 2020.  doi:10.1128/JCM.02572-20.

ESGBIES & ESGICH

• A clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa (IRONIC study).
  Gudiol C, Albasanz-Puig A, Laporte-Amargós J, et al. Antimicrob Agents Chemother 2020 pii: AAC.02494-19. doi: 10.1128/AAC.02494-19.

ESGMYC & ESGITM & EITaF

• Tools to implement the WHO End TB Strategy: Addressing common challenges in high and low endemic countries.
  Al Abri S, Kasaeva T, Migliori GB, et al. Int J Infect Dis. 2020 pii: S1201-9712(20)30100-4. doi: 10.1016/j.ijid.2020.02.042.

ESGMYC & EUCAST

• What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex?
  Schön T, Köser C U, Werngren J et al. Clin Microbiol Infect. 2020; 26:1453-1455. doi: 10.1016/j.cmi.2020.07.037.
• Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
  Schön T, Werngren J, Machado D et al. Clin Microbiol Infect 2020; in press. doi: 10.1016/j.cmi.2020.10.019.
• Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - the EUCAST broth microdilution reference method for MIC determination.
  Schön T, Werngren J, Machado D et al. Clin Microbiol Infect 2020; 26:1488-1492. doi: 10.1016/j.cmi.2020.07.03

ESGVM & ESGHAMI

• One Health: a multifaceted concept combining diverse approaches to prevent and control antimicrobial resistance.
  Luca Guardabassi, Patrick Butaye, D.H. Dockrell et al. Clin Microbiol Infect 2020; 26:1604-1605. doi: 10.1016/j.cmi.2020.07.012.

To top